Accelerate Diagnostics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $2,975 | $2,986 | $2,921 | $3,000 |
Gross Profit | 856 | 676 | 723 | 606 |
EBITDA | -8,618 | -8,122 | -10,922 | -9,486 |
EBIT | -9,496 | -8,999 | -11,780 | -10,306 |
Net Income | -14,639 | -11,588 | -14,230 | -13,000 |
Net Change In Cash | 2,975 | 2,986 | 2,921 | 3,000 |
Free Cash Flow | -2,576 | -7,585 | -8,965 | -7,865 |
Cash | 19,691 | 8,588 | 14,606 | 12,138 |
Basic Shares | 24,915 | 23,058 | 19,216 | 14,569 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $12,059 | $12,752 | $11,782 | $11,165 |
Gross Profit | 2,550 | 3,303 | -381 | 4,459 |
EBITDA | -49,771 | -55,799 | -59,594 | -59,656 |
EBIT | -53,025 | -58,799 | -62,112 | -62,653 |
Net Income | -61,618 | -62,493 | -77,702 | -78,208 |
Net Change In Cash | 12,059 | 12,752 | 11,782 | 11,165 |
Cost of Revenue | 4,117 | -25,233 | ||
Free Cash Flow | -41,230 | -49,282 | -47,926 | -51,756 |
Cash | 12,138 | 34,905 | 39,898 | 35,781 |
Basic Shares | 12,477 | 6,172 | 6,172 | 5,601 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.59 |
2024-06-30 | -$0.53 |
2024-03-31 | -$0.88 |
2023-12-31 | -$0.81 |
